STOCK TITAN

[SCHEDULE 13G/A] QIAGEN N.V. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Wellington Management entities disclosed beneficial ownership of 26,023,940 shares of Qiagen N.V. (CUSIP N72482206), equal to 11.95% of the outstanding common stock. The filing shows shared voting power of 20,289,753 shares and shared dispositive power of 26,023,940 shares. The reporting persons are multiple Wellington entities, some classified as holding companies and one as an investment adviser, and the securities are owned of record by clients of Wellington investment advisers. The statement affirms the holdings are held in the ordinary course of business and not for the purpose of changing or influencing issuer control.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Wellington holds a material, passive equity stake in Qiagen: 26.0M shares (11.95%), with shared voting/dispositive power.

Wellington Management's Schedule 13G/A reports a substantial position that exceeds common investor thresholds and therefore is material to ownership tables. The filing classifies the holdings as passive (Schedule 13G), and voting/dispositive power is shared across Wellington entities, with 20,289,753 shares showing shared voting power. This disclosure may affect investor perception of ownership concentration but contains no indication of an active control campaign or planned changes to governance.

TL;DR: A significant institutional stake is disclosed, but the filer states it is held in the ordinary course and not to influence control.

The filing identifies multiple Wellington affiliates as reporting persons, including holding companies and an investment adviser. The securities are held of record by clients of the Wellington advisers. Because this is a Schedule 13G/A rather than a 13D, the filer represents passive intent; therefore, this disclosure signals ownership concentration without an expressed governance agenda. Investors and the company may monitor engagement but no governance action is declared in this filing.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Wellington Management Group LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:08/12/2025
Wellington Group Holdings LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:08/12/2025
Wellington Investment Advisors Holdings LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:08/12/2025
Wellington Management Company LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:08/12/2025

FAQ

How many Qiagen (QGEN) shares does Wellington Management report owning?

Wellington Management reports beneficial ownership of 26,023,940 shares of Qiagen common stock.

What percentage of Qiagen does the Wellington stake represent?

The reported stake represents 11.95% of Qiagen's outstanding common stock.

Does Wellington have sole voting or dispositive power over these QGEN shares?

No. The filing shows 0 shares with sole voting or dispositive power and shared voting power of 20,289,753 and shared dispositive power of 26,023,940.

Are these shares held for control or active influence over Qiagen?

The filing certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Which Wellington entities are named as reporting persons on the Schedule 13G/A?

The reporting persons include Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP.
Qiagen

NYSE:QGEN

QGEN Rankings

QGEN Latest News

QGEN Latest SEC Filings

QGEN Stock Data

10.05B
215.75M
1.61%
88.24%
3.1%
Diagnostics & Research
Healthcare
Link
Netherlands
Venlo